[Specific modification of the immune system with CpG-oligonucleotides].
Krug
A
A
Hartmann
G
G
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D017951:Antigen Presentation / Q000187:drug effects; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D004195:Disease Models, Animal; D006801:Humans; D007107:Immune System / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D009838:Oligodeoxyribonucleotides / Q000494:pharmacology*
D000276:Adjuvants, Immunologic; C408982:CPG-oligonucleotide; D009838:Oligodeoxyribonucleotides